Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros












Base de datos
Intervalo de año de publicación
1.
Orthop Traumatol Surg Res ; 104(5): 597-602, 2018 09.
Artículo en Inglés | MEDLINE | ID: mdl-29969721

RESUMEN

HYPOTHESIS: Percutaneous pedicle screw fixations (PPSF) are increasingly used in spine surgery, minimizing morbidity through less muscle breakdown but at the cost of intraoperative fluoroscopic guidance that generates high radiation exposure. Few studies have been conducted to measure them accurately. MATERIAL AND METHODS: The objective of our study is to quantify, during a PPSF carried out in different experimented centers respecting current radiation protection recommendations, this irradiation at the level of the surgeon and the patient. We have prospectively included 100 FPVP procedures for which we have collected radiation doses from the main operator. For each procedure, the doses of whole-body radiation, lens and extremities were measured. RESULTS: Our results show a mean whole body, extremity and lens exposure dose per procedure reaching 1.7±2.8µSv, 204.7±260.9µSv and 30.5±25.9µSv, respectively. According to these values, the exposure of the surgeon's extremities and lens will exceed the annual limit allowed by the International Commission on Radiological Protection (ICRP) after 2440 and 4840 procedures respectively. CONCLUSION: Recent European guidelines will reduce the maximum annual exposure dose from 150 to 20mSv. The number of surgical procedures to not reach the eye threshold, according to our results, should not exceed 645 procedures per year. Pending the democratization of neuronavigation systems, the use of conventional fluoroscopy exposes the eyes in the first place. Therefore they must be protected by leaded glasses. LEVEL OF PROOF: IV, case series.


Asunto(s)
Fluoroscopía , Exposición Profesional/análisis , Procedimientos Ortopédicos , Exposición a la Radiación , Adulto , Anciano , Anciano de 80 o más Años , Extremidades , Dispositivos de Protección de los Ojos , Femenino , Humanos , Cristalino , Vértebras Lumbares/cirugía , Masculino , Persona de Mediana Edad , Exposición Profesional/prevención & control , Exposición Profesional/normas , Salud Laboral/normas , Tornillos Pediculares , Estudios Prospectivos , Protección Radiológica , Cirugía Asistida por Computador , Vértebras Torácicas/cirugía , Adulto Joven
2.
Mov Disord ; 25(3): 289-99, 2010 Feb 15.
Artículo en Inglés | MEDLINE | ID: mdl-20063427

RESUMEN

Long-term efficacy of internal globus pallidus (GPi) deep-brain stimulation (DBS) in DYT1 dystonia and disease progression under DBS was studied. Twenty-six patients of this open-label study were divided into two groups: (A) with single bilateral GPi lead, (B) with a second bilateral GPi lead implanted owning to subsequent worsening of symptomatology. Dystonia was assessed with the Burke Scale. Appearance of new symptoms and distribution according to body region were recorded. In the whole cohort, significant decreases in motor and disability subscores (P < 0.0001) were observed at 1 year and maintained up to 10 years. Group B showed worsening of the symptoms. At 1 year, there were no significant differences between Groups A (without subsequent worsening) and B; at 5 years, a significant difference was found for motor and disability scores. Within Group B, four patients exhibited additional improvement after the second DBS surgery. In the 26 patients, significant difference (P = 0.001) was found between the number of body regions affected by dystonia preoperatively and over the whole follow-up. DBS efficacy in DYT1 dystonia can be maintained up to 10 years (two patients). New symptoms appear with long-term follow-up and may improve with additional leads in a subgroup of patients.


Asunto(s)
Estimulación Encefálica Profunda/métodos , Distonía/terapia , Adolescente , Adulto , Anciano , Evaluación de la Discapacidad , Distonía/genética , Femenino , Globo Pálido/fisiología , Humanos , Estudios Longitudinales , Masculino , Persona de Mediana Edad , Chaperonas Moleculares/genética , Estudios Retrospectivos , Índice de Severidad de la Enfermedad , Adulto Joven
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...